1. Home
  2. FF vs CTNM Comparison

FF vs CTNM Comparison

Compare FF & CTNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FF
  • CTNM
  • Stock Information
  • Founded
  • FF N/A
  • CTNM 2009
  • Country
  • FF United States
  • CTNM United States
  • Employees
  • FF N/A
  • CTNM N/A
  • Industry
  • FF Major Chemicals
  • CTNM
  • Sector
  • FF Industrials
  • CTNM
  • Exchange
  • FF Nasdaq
  • CTNM Nasdaq
  • Market Cap
  • FF 176.1M
  • CTNM 142.3M
  • IPO Year
  • FF N/A
  • CTNM 2024
  • Fundamental
  • Price
  • FF $4.29
  • CTNM $5.77
  • Analyst Decision
  • FF
  • CTNM Strong Buy
  • Analyst Count
  • FF 0
  • CTNM 4
  • Target Price
  • FF N/A
  • CTNM $22.50
  • AVG Volume (30 Days)
  • FF 196.3K
  • CTNM 366.4K
  • Earning Date
  • FF 08-11-2025
  • CTNM 08-12-2025
  • Dividend Yield
  • FF 5.61%
  • CTNM N/A
  • EPS Growth
  • FF N/A
  • CTNM N/A
  • EPS
  • FF N/A
  • CTNM N/A
  • Revenue
  • FF $202,596,000.00
  • CTNM N/A
  • Revenue This Year
  • FF N/A
  • CTNM N/A
  • Revenue Next Year
  • FF N/A
  • CTNM N/A
  • P/E Ratio
  • FF N/A
  • CTNM N/A
  • Revenue Growth
  • FF N/A
  • CTNM N/A
  • 52 Week Low
  • FF $3.77
  • CTNM $3.35
  • 52 Week High
  • FF $6.40
  • CTNM $21.58
  • Technical
  • Relative Strength Index (RSI)
  • FF 61.47
  • CTNM N/A
  • Support Level
  • FF $4.04
  • CTNM N/A
  • Resistance Level
  • FF $4.17
  • CTNM N/A
  • Average True Range (ATR)
  • FF 0.10
  • CTNM 0.00
  • MACD
  • FF 0.02
  • CTNM 0.00
  • Stochastic Oscillator
  • FF 87.29
  • CTNM 0.00

About FF FutureFuel Corp. Common shares

FutureFuel Corp makes and sells diversified chemical products, bio-based fuel products, and specialty chemical products. The company is organized into two segments based on product type: biofuels and chemicals. The biofuel segment sells biodiesel and other petroleum products. Its fuels are made from a mix of diesel, vegetable oils, and grease feedstock. The chemicals segment sells products that are used in the production of agricultural chemicals, which include herbicides, coatings, and cleaning products, such as detergents.

About CTNM Contineum Therapeutics Inc. Class A Common Stock

Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.

Share on Social Networks: